Details:

Corporate Authors:
Centers for Disease Control and Prevention (U.S.) ; National Center for Emerging Zoonotic and Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. Antibiotic Resistance Coordination and Strategy Unit .
Centers for Disease Control and Prevention (U.S.) ; National Center for Emerging Zoonotic and Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. Antibiotic Resistance Coordination and Strategy Unit . Less -
Description:
Type: Bacteria

Also known as: Extended-spectrum β-lactamase

About: ESBL-producing Enterobacteriaceae are a concern in healthcare settings and the community. They can spread rapidly and cause or complicate infections in healthy people.

ESBL stands for extended-spectrum beta-lactamase. ESBLs are enzymes that break down commonly used antibiotics, such as penicillins and cephalosporins, making them ineffective.

Estimated cases in hospitalized patients in 2017: 197,400

Estimated deaths in 2017: 9,100

This fact sheet is part of CDC’s 2019 Antibiotic Resistance Threats Report.

The full report, including data sources, is available at www.cdc.gov/DrugResistance/Biggest-Threats.html.

CS298822-A

Publication date from document properties.

esbl-508.pdf


Subject:
[+]
Anti-Bacterial Agents
Anti-Infective Agents
Antimicrobial Stewardship
Drug Resistance, Microbial
Enterobacteriaceae
Enterobacteriaceae Infections

Series:
CDC’s 2019 Antibiotic Resistance Threats Report
Document Type:
Pamphlet (or booklet)
Genre:
Fact Sheet
Place as Subject:
United States
Collection(s):
Stephen B. Thacker CDC Library collection
Main Document Checksum:
[+]
urn:sha256:1b1b33a8062c6908d785e7758315696936e0d5bef3f94ede94c429d0ce954322
File Type:

Supporting Files

• 	ESBL.html	htm
  	Biggest-Threats.html	htm

More +